1. Live ledgerobs22878 noopen/pending/closing, only2operatorliquidationwins; cannot estimate empiricalloss. Fund278.67/account850.99/positioncap212.7475. 2. Reuse frozen AVAV1814CLI diagnostic74trades+72.9481% notholdout;1815 vectorbtcosted20/10 train-24.4721%,holdout+50.033%,DD52.0352%,N6,p33.33%,avgwin60.1045/loss11.6583; known1818CI[-13.556,44.997]% and unvalidated15minexits prevent assigning tradeodds. No repeated/relabelledbacktest. 3. FrozenFTK1895/2238/2266 holdout-63.6175%,DD67.1654%,N10,p30%,avgwin19.6007341/loss19.2995217%; Pythonobs22893 expectancy-7.62944496%,rawhalfKelly-.1946214,clipped0. Source https://runway.adityaperswal.workers.dev/data/stock-bars . Other priorrejections2266 unchanged. 4. Neworiginalchecks do not remove constraints; https://investor.avinc.com/node/21396/html revenue-recognition schedule notcash. Conclusion retain278.67cash; no orders, exits or fabricated3Rtarget. PositiveAVAVholdout is strongest countercase; method mismatch and selected tiny sample remain unsolved. No currentquote needed forzeroeligibleentry; do not use historicalIEXasquote. Cashchosen for absent validated asymmetricnetpayoff, notfear/monthly349.01gap. No new strategy/simulation/backtest claimed.
fund_cash278.67
position_cap212.75
AVAV_train_pct-24.47
AVAV_holdout_pct50.03
AVAV_holdout_n6
FTK_holdout_pct-63.62
FTK_holdout_n10
FTK_expectancy_pct-7.63
raw_half_Kelly-0.19
approved_half_Kelly0
new_orders0
EXTRA910 demand growth requires delivery, acceptance and cash
Premises from obs22892/93 and https://investor.avinc.com/news-releases/news-release-details/aerovironment-announces-fiscal-2027-first-quarter-results ; https://www.sec.gov/Archives/edgar/data/928054/000092805426000087/ex992-lakestreetinvestor.htm . First order: funded defense orders or expanded Saudi chemistry activity require inputs/capacity. Second: vendors and labor receive spending before contractors necessarily collect; acceptance, contract type and cost recovery decide rent capture. Third: successful conversion can fund further growth, but delays can require workingcapital/financing and transfer benefit to suppliers. These are conditional chains, not measured forecasts. Start278.67cash; goal asymmetric netpayoff; bindingconstraint independently validated entry/exitedge plus unverified incremental realization. Strong counterexample is profitable expansion despite temporarynegativeFCF; that upgrades fundamental outlook but does not validate an entry today. No probability estimated from conference silence.
cash278.67
AVAV_equipment_software_m49.45
AVAV_OCF_m13.5
FTK_H2_forecast_floor_m40
approved_usd0
EXTRA910 conference access gap leaves cash-conversion thesis unresolved
Premises:1. Exchange fresh funding BTC1/ETH-.8275/SOL-.1599bp; coinOI16:32→18:30 +.0467/-3.3256/-1.1569%. 2. Primary Liquidtip advances118; secondendpointtimeout, operatorhash and watchedbalances unchanged. 3. Circle remains Sep7 circulation74.28bn,7dayissuance8.8/redemption7.86bn; no new Sep10 issuerflow. Firstorder fewer ETH/SOL grosscontracts on OKX and continued primaryblockrecords. Secondorder hypotheses lower leverage/settlement capacity; thirdorder possible changes in allocation/confidence. Counterexamples newshorts offsetlongs, otherexchangesoffsetOI, advancingblocks coexistwithrestrictedpegouts; no authenticatedpayout implied. Networkusers could benefit if service works, tokenholdersneednot capturevalue. Facts end at API/issueroutputs; no surprise or causal elasticity measured. Therefore no trade from headlines or thisoneincident. Sources https://www.okx.com/api/v5/public/open-interest ; https://www.okx.com/api/v5/public/funding-rate ; https://blockstream.info/liquid/api/blocks ; https://www.circle.com/transparency .
BTC_OI_change_pct0.05
ETH_OI_change_pct-3.33
SOL_OI_change_pct-1.16
Liquid_tip4051602
Liquid_tip_change118
USDC_net7d_bn0.94
USDC_net30d_bn2.22
approved0
QTR9101828 AVAV remains a closing-signal paper watch
Premises:1.Frozen note1683/monitor161 requires EAR=AVAV(Sep10close/Sep4close-1)-SPYsame,Sep7holiday. At18:30UTC Sep10close unavailable, regardless of currentdroneheadlines.2.PositiveEAR createsSep11openfive-sessionpaper candidate,not validatedtrade; nonpositiveEAR createscontrol.3.Existingcosted15minN9CI[-.7874,5.5167]%crosses0 andwhole-share/greenexit reproduction unresolved. Paper1ADRstop/1.5ADRtarget doesnotmeet currentactualtrade>=3Rtarget requirement, so it cannot silentlybe promoted.4.Countryrankcollector15 haseligible0,no monthlycatchup. Conclusion preserve21UTCmonitor161, no order or inventedintradayprice. A higher target would constitute a different rule needing validation, not a freefix. Sources obs22876/AVAVoriginal; https://investor.avinc.com/node/21391 ; https://runway.adityaperswal.workers.dev/data/stock-bars ; prior2256.
historical sample9
CI low pct-0.79
CI high pct5.52
paper target R1.5
current required target R3
eligible orders0
QTR9101828 frozen negative edge still gives zero half-Kelly
Premises:1.Freshledger has3 closed trades, all operator liquidations, and0open/pending/closing. They censor intended4–6week outcomes, so cannot estimate intended stop/target probabilities or execution slippage.2.Saved2255/2208/2209 costed gap holdoutN2151 return-26.212876%,DD27.351241%,winrate43.979544398%,72monthlyclusters meanCI[-.165928,-.052452]%,stressedreturn-56.878654%. Reused evidence, not a rerun/newsample.3.Python recomputation p=.43979544398,W=.617581664%,L=.682768517% yields-.1108804318176%mean; halfKelly=max(0,.5*(p-(1-p)/(W/L)))=0. Conclusion no entry under currenthalfKelly even though oldernotes usedquarterKelly. Validity correct conditional on imported outcomes; soundness limited by vendorhistory/cost assumptions and selection. Counterexample sustainednewregime might reverseexpectancy, but intradayrally/onepaperwin cannot independently demonstrate it. No newparameter sweep justified in tradingreview. Source obs22873; https://runway.adityaperswal.workers.dev/data/stock-bars ; saved2255.
holdout sample2151
saved return pct-26.21
saved drawdown pct27.35
win rate43.98
mean net pct-0.11
half Kelly0
fund USD187.22
position cap USD212.75
normal risk cap USD25.53
C9101830 frozen half-Kelly audit: all allocations remain zero
Premises:1. Re-read2183-85: supplied hourly holdouts BTC-14.9605%,ETH-15.5393%,SOL-6.6888%,daily-8.6832/-9.5346/-3.5641%; all36 hourly variants lose. 2025training and REUSED2026Jan1-Sep9holdout,25bpfees/side10bpslippage20stress. 2. Python recomputed pW-(1-p)L and requested halfKelly .5*(p-(1-p)/(W/L)), observation22873 (verify returned ID). 3. One forced liquidation cannot calibrate setup probability. Conclusion zeroallocation; audit not new experiment. Validity holds under positive-expectancy requirement; soundness limited by smallsample/reusedholdout/history. Counterexample another strategy can profit; price rally alone not new evidence for this rule. Frozen1.5R target/old+1Rexit discussion does not satisfy current>=3R/+2Rquarter policy. New compliant strategy requires independent daily/hourly costed15minexecution test; do not simply triple historicaltargets or retune reusedwindow. Sources https://runway.adityaperswal.workers.dev/data/crypto-bars and stored2183-2185.
BTC_E-1.27
ETH_E-1.77
SOL_E-0.74
BTC_halfKelly-0.23
ETH_halfKelly-0.35
SOL_halfKelly-0.1
BTC_N12
ETH_N9
SOL_N8
allocation0
LUNCH910 decision: retain $49.14 cash; no proposals
Start state: no open, pending or closing catalyst lots; fund49.14 cash and account850.99 from supplied context. Goal: repeatable pre-event returns. Binding constraint: independently validated costed edge. Premise1: frozen EPM training-6.551%, six-event CI crosseszero and stressed netRR1.08023 fail; delayed paper3.8 at16:16 is+.62927R, not a completed new validation event. Premise2: LOVE released before open; full10Q verifies refundcash but H1OCF+investing-23.633m, exact oldguidance bridge unknown and existing holdout-2.34135%. Premise3: TLX generic momentum has negative training and no validated FDA cohort; issuerSep11date verified but currentdecision not established by boundedRSS. SRRKpublicreplay unread. Premise4: no supported order requires fresh execution pricing; delayed SIP is historical only. Conclusion noPROPOSE/EXIT/ADJUST/FUND, approvedKelly0. Strongest counterargument: affordable EPM whole shares and improving tape may yield a base hit; this does not satisfy necessary cost/validation gates. Validity follows failed prerequisites; soundness limited to frozen selected history and named source gaps, not a universal claim of no market opportunity. Existing backtests and simulation reviewed without rerunning or retuning; no new backtest claimed. 200/201resolved;208/209next19:40,168Sep14paperexit retained. Newcollector schedule rejected at5jobcap; preservefive andmanualcheck208. Lessons669–671 recorded. Sources https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-schedules-fiscal-q4-and-full-year-2026 ; https://www.sec.gov/Archives/edgar/data/1701758/000162828026061220/love-20260802.htm ; https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/ ; https://runway.adityaperswal.workers.dev/data/stock-bars ; runway:query_research?fund=catalyst (2261–2265) ; runway:query_trades?fund=catalyst .
fund_cash49.14
account_equity850.99
account_risk_limit8.51
position_cap212.75
approved_allocation0
EPM_stress_RR1.08
EPM_train_pct-6.55
EPM_last_delayed3.8
EPM_mark_R0.63
active_jobs5
armed_monitors20
new_orders0
LUNCH910 trading decision: retain all $278.67 in cash
Premises: LOVE reported21m cash refunds yet H1 operating plus investing cash was-23.633m; SRRK and TLX remain exposed to pipeline/manufacturing decisions whose current resolution was not verified by the bounded feed checks. First order: refunds increase available cash; actual FDA clearance, if granted, removes a specific regulatory obstacle. Second order: furniture innovation/onshoring consumes investment before sales; radiopharma or biologic launch requires capacity, supply and payer access even after approval. Third order: equity value depends on retained incremental cash after reinvestment, competition and financing dilution, not the headline alone. Issuers benefit from optimism; suppliers/customers may capture part of economic gains. Strong counterargument: successful new products and labeling can create durable high-margin demand. That would improve fundamentals, but cannot supply an unmeasured short-window stock probability. These are conditional mechanisms, not causal estimates or claims that LOVE is distressed. Sources https://www.sec.gov/Archives/edgar/data/1701758/000162828026061220/love-20260802.htm ; https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/ ; https://investors.scholarrock.com/investors-media/press-releases .
LOVE_refund_m21
LOVE_H1_cash_after_investing_m-23.63
allocation0
LUNCH910 retain frozen simulation; intraday mark is not a new distribution
Re-read recorded NumPy simulation1942, not rerun or refit. Premise1: seed2026091003 sampled six stressed event returns independently over50000 paths of10 events, initial49.14, descriptive raw quarter-Kelly .063805896. Premise2: mean49.352116, p05/median/p95=48.845875/49.352178/49.856086 and loss probability24.838%. Premise3: today's .674R partial-day mark has no finished event return and must not enter the resampling pool. Conclusion: approved size remains0 because negative training, CI crossing zero and netRR1.08023 fail independently. Validity is conditional on the frozen empirical sample; soundness does not extend to binary gaps, dependence, new regimes or a September profit forecast. Countercase prospective events may improve calibration; freeze and collect them instead of importing a favorable intraday mark. Source runway:query_research?fund=catalyst&analysisKind=simulation&symbol=EPM (1942); https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=EPM&feed=sip&adjustment=all .
paths50000
events10
initial49.14
raw_fraction0.06
mean49.35
p0548.85
median49.35
p9549.86
loss_probability_pct24.84
approved_allocation0
LUNCH910 frozen validation still requires zero allocation
This is a review of recorded tests, not a new backtest or an independent holdout. Premise 1: EPM backtest1928 had all12 training cells negative; preferred training -6.5511%, six-event holdout +3.8230%, win probability4/6, average win2.6432%, loss3.2626%, drawdown3.9565%, bootstrap mean CI[-1.77895,3.06512]%. Raw quarter-Kelly .0638059 is descriptive, approved allocation0. Premise2: LOVE1677 stressed holdout N10, p20%, W10.7024%/L2.7538%, return-2.34135%, DD12.9858%, CI crosses0. Premise3: TLX2167 generic momentum training-25.273%, holdoutN19+11.0352%, p9/19,W6.5854%/L4.4908%,DD23.9874%, CI[-2.0924,3.5902]%; not FDA-event validation. Premise4: current trade query contains3 losses,2 operator liquidations; this tiny censored sample cannot estimate new-event win odds or routine slippage. Conclusion: EPM's partial-day paper gain supplies no completed additional outcome; retain failed gates without retuning. A favorable new regime is the strongest countercase, but must be tested prospectively with costs and event timing. Sources runway:query_research?fund=catalyst (1928,1677,2167,2247); runway:query_trades?fund=catalyst ; https://runway.adityaperswal.workers.dev/data/stock-bars .